Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition

Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and n...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation biology Vol. 78; no. 5; pp. 341 - 346
Main Authors Baria, K., Warren, C., Eden, O. B., Roberts, S. A., West, C. M., Scott, D.
Format Journal Article
LanguageEnglish
Published London Informa UK Ltd 01.05.2002
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Materials and methods : Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. Results : The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). Conclusions : The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers.
AbstractList To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers.
Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Materials and methods : Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. Results : The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). Conclusions : The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers.
PURPOSETo investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance.MATERIALS AND METHODSStimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells.RESULTSThe assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004).CONCLUSIONSThe results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers.
To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers.
Author Eden, O. B.
West, C. M.
Warren, C.
Scott, D.
Roberts, S. A.
Baria, K.
Author_xml – sequence: 1
  givenname: K.
  surname: Baria
  fullname: Baria, K.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
– sequence: 2
  givenname: C.
  surname: Warren
  fullname: Warren, C.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
– sequence: 3
  givenname: O. B.
  surname: Eden
  fullname: Eden, O. B.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
– sequence: 4
  givenname: S. A.
  surname: Roberts
  fullname: Roberts, S. A.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
– sequence: 5
  givenname: C. M.
  surname: West
  fullname: West, C. M.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
– sequence: 6
  givenname: D.
  surname: Scott
  fullname: Scott, D.
  organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15245022$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12020425$$D View this record in MEDLINE/PubMed
BookMark eNqFkU2LFDEQhoOsuLOrP8CL5KK30UrS6Q_1IoNfsOBFz02SruxkSSdtkl6Zf2-WGVlEWCGQgvd5i3qrLshZiAEJec7gNYMe3sAgpQAAxurrhBwekQ0TLd-KqpyRzZ1ea-Dn5CLnm0pyEP0Tcs54rRouN0Tv9inOMcdZeZrU5GLGkF1xt64cqAv0ENdwTY0KBhNdVHEYSn5Ll5iz0x4p3roJq0ijpdcYsDhDl4STyxWpfWJ4Sh5b5TM-O_2X5Menj993X7ZX3z5_3X242pqmFWWL0FqQNVCjDehOKz2otgHQTDENggs2SMM4Qz0ADrJnXWftNLGpayaw0opL8urYd0nx54q5jLPLBr1XAeOax451NXTb_Bdkfc8BOllBdgRNqnET2nFJblbpMDIY7y4w_nOB6nlxar7qGad7x2nlFXh5AlQ2yttUV-vyPSd5I4Hzyr0_ci7YmGb1KyY_jUUdfEx_TOKhOd79Zd-j8mVvVMLxJq4p1Es8kOI3mzG1tA
CitedBy_id crossref_primary_10_1002_em_20274
crossref_primary_10_1016_j_radonc_2011_09_021
crossref_primary_10_1088_0952_4746_28_1_N01
crossref_primary_10_1002_em_20633
crossref_primary_10_1093_mutage_gen009
crossref_primary_10_1111_j_1365_2141_2004_05166_x
crossref_primary_10_1159_000077517
crossref_primary_10_1038_sj_bjc_6604345
crossref_primary_10_1038_sj_bjc_6602807
crossref_primary_10_1093_mutage_ges006
crossref_primary_10_1016_S0360_3016_03_00664_3
crossref_primary_10_3109_09553002_2010_496027
crossref_primary_10_1093_mutage_gei040
crossref_primary_10_1016_j_cancergencyto_2004_05_018
crossref_primary_10_1016_j_mrfmmm_2004_11_002
crossref_primary_10_1007_s10549_011_1940_1
crossref_primary_10_1016_S0167_8140_02_00167_6
crossref_primary_10_1016_j_mrrev_2016_09_001
crossref_primary_10_1093_mutage_ges040
crossref_primary_10_1097_00004032_200307000_00013
crossref_primary_10_3389_fonc_2020_01338
crossref_primary_10_1148_rg_235035040
crossref_primary_10_1667_RR1943_1
crossref_primary_10_1016_j_radonc_2007_04_010
crossref_primary_10_1038_sj_bjc_6604514
crossref_primary_10_1097_01_cej_0000199502_23195_29
crossref_primary_10_1186_2041_9414_1_8
crossref_primary_10_1080_09553000500147642
crossref_primary_10_3109_09553002_2011_622032
crossref_primary_10_1080_09553000500280500
crossref_primary_10_1016_j_mrgentox_2010_03_016
crossref_primary_10_1667_RR14862_1
crossref_primary_10_1038_sj_onc_1206883
ContentType Journal Article
Copyright 2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002
2003 INIST-CNRS
Copyright_xml – notice: 2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002
– notice: 2003 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
8FD
C1K
FR3
P64
RC3
7X8
DOI 10.1080/09553000110117359
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Engineering Research Database
Technology Research Database
Toxicology Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Sciences (General)
Biology
EISSN 1362-3095
EndPage 346
ExternalDocumentID 10_1080_09553000110117359
12020425
15245022
11373383
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
00X
03L
0BK
0R~
29J
36B
4.4
53G
5GY
5RE
5VS
8WZ
A6W
A8Z
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
AAUGY
ABBKH
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ABWCV
ABZEW
ACENM
ACFUF
ACGEJ
ACGFS
ACKZS
ACLSK
ADCVX
ADFCX
ADFOM
ADFZZ
ADRBQ
ADXPE
AECIN
AEIIZ
AENEX
AEOZL
AEXWM
AEYQI
AFFNX
AFKVX
AFLEI
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJVHN
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
AWYRJ
BABNJ
BLEHA
BOHLJ
BRMBE
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DU5
DWTOO
EAP
EAS
EBB
EBC
EBD
EBO
EBS
EBX
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
F5P
H13
HZ~
J.N
J5H
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
O9-
P2P
QQXMO
Q~Q
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TH9
TUS
UDS
UEQFS
V1S
X7M
ZGI
ZXP
~1N
ABJNI
ABLIJ
ABMYL
ABXYU
ESTFP
P0W
IQODW
AAORF
ACIEZ
ALYBC
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
TBQAZ
TDBHL
TERGH
TUROJ
AAYXX
CITATION
7U7
8FD
C1K
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c463t-e06f055534bc0b7bab9a6400b1a1b0323195c121eb90e958177ffdd1d74d0f5f3
ISSN 0955-3002
IngestDate Fri Oct 25 08:27:42 EDT 2024
Thu Oct 24 20:41:15 EDT 2024
Thu Sep 26 16:22:31 EDT 2024
Tue Oct 15 23:25:32 EDT 2024
Sun Oct 22 16:09:28 EDT 2023
Thu Mar 14 07:16:33 EDT 2024
Wed Jun 21 08:15:12 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c463t-e06f055534bc0b7bab9a6400b1a1b0323195c121eb90e958177ffdd1d74d0f5f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 12020425
PQID 18820075
PQPubID 23462
PageCount 6
ParticipantIDs informaworld_taylorfrancis_310_1080_09553000110117359
crossref_primary_10_1080_09553000110117359
pascalfrancis_primary_15245022
informahealthcare_journals_10_1080_09553000110117359
pubmed_primary_12020425
proquest_miscellaneous_71720464
proquest_miscellaneous_18820075
PublicationCentury 2000
PublicationDate 2002-05-01
PublicationDateYYYYMMDD 2002-05-01
PublicationDate_xml – month: 05
  year: 2002
  text: 2002-05-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle International journal of radiation biology
PublicationTitleAlternate Int J Radiat Biol
PublicationYear 2002
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
SSID ssj0002038
Score 1.8701751
Snippet Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier...
To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies...
PURPOSETo investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies...
SourceID proquest
crossref
pubmed
pascalfrancis
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 341
SubjectTerms Adolescent
Adult
Age of Onset
Biological and medical sciences
Case-Control Studies
Child
Child, Preschool
Chromosome Aberrations
Chromosomes, Human - genetics
Chromosomes, Human - radiation effects
Female
G2 Phase
Humans
In Vitro Techniques
Infant
Lymphocytes - radiation effects
Male
Medical sciences
Middle Aged
Neoplasms - genetics
Radiation Tolerance - genetics
Space life sciences
Title Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition
URI https://www.tandfonline.com/doi/abs/10.1080/09553000110117359
https://www.ncbi.nlm.nih.gov/pubmed/12020425
https://search.proquest.com/docview/18820075
https://search.proquest.com/docview/71720464
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJxAvaCu3chl-4AGoEtlxnDS8tWPTxAQ8sEp7i-LEFpVYMqXtw_gv_Fd8YufW0Qn2ElVWkiY6n885Pvn8HYTeTiVTIZfKYYQovUAR0hGR9B3BdK7g0wRiPrAtvganC__zBb8YDH53WEubtXDTX3_dV3IXq-oxbVfYJfsflm1uqgf0b21ffdQW1sd_sjEo214Wq-IS1PmTbFmsgI5u-0Es88k1TGXgdaWyrBVUKwrcVQFT4aecSNtUFHJG_TewoxFkA7Jlw-bqZq_98mFHdAL-3CDJijq1BdLSsHHP3LZ0X5bG1x01Y8fW-31zJ_Nm0JC-K5x9dyczt1eg8Fo6oFm02m1Vi7MOUckUIDkgxPhiadwv7OFixLTdrP1zOO3gkHecLTOSWTZuM1PKvBESLIcygv5IlUIepSGzKuR9pW1ay6Vun3sP7Xnaj02HaG82_zQ_aUK9R6pW6c2r1J_NQbx9-ya9xGffyuL-aEh-W1K5wNFNVnqaKtNfZfcCqEqEzvfRI7uCwTMDxwM0kPkI3Tc9Ta9H6MEXy9YYoQMbOFb4nVU3f_8YiQ5o8TZo8TLHFWixAS2uQfsR15DFNWRxobCFLO5D9glanByfH506ttGHk_oBWzuSBAqE55gvUiJCkYgoCXRwETShgjC9BIl4Sj0qRURkxKc0DJXKMpqFfkYUV-wpGuZFLp8jnAkaRAp0BVniq0AknvJIFojIy0RCWDhGH2orxFdGzyXeafcx8m_YKbaTa3XbZbxrynhd1d6sIWN2y3WHPZu3D8g9n-tke4ze1CCIdRSAT3tJLouNfha9UIbsf_cZIYV2VIE_Rs8Metq7e7BB3uMv7va2L9HDdta_QsN1uZGvdaK-Fod2uvwBR9jhww
link.rule.ids 315,783,787,27938,27939
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chromosomal+radiosensitivity+in+young+cancer+patients%3A+possible+evidence+of+genetic+predisposition&rft.jtitle=International+journal+of+radiation+biology&rft.au=Baria%2C+K.&rft.au=Warren%2C+C.&rft.au=Eden%2C+O.+B.&rft.au=Roberts%2C+S.+A.&rft.date=2002-05-01&rft.pub=Informa+UK+Ltd&rft.issn=0955-3002&rft.eissn=1362-3095&rft.volume=78&rft.issue=5&rft.spage=341&rft.epage=346&rft_id=info:doi/10.1080%2F09553000110117359&rft.externalDocID=10_1080_09553000110117359
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0955-3002&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0955-3002&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0955-3002&client=summon